Search research articles
Contact Us
Filters
Showing results (341-350 of 408) with videos related to
Page
of 41
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 9, 2008
Safety and antiviral activity of albinterferon alfa-2b in prior interferon nonresponders with chronic hepatitis C
David R Nelson, Vinod Rustgi, Vijayan Balan, et al.
Open Forum Infectious Diseases
|
May 8, 2026
Non-Hispanic Black Persons With HIV Have a Lower Risk of Metabolic Dysfunction-Associated Steatotic Liver Disease and Clinically Significant Fibrosis Compared to Non-Hispanic White and Hispanic Individuals
Tinsay A Woreta, Samer Gawrieh, Laura A Wilson, et al.
Journal of Viral Hepatitis
|
March 4, 2024
Leveraging opportunities for treatment/user simplicity (LOTUS): Navigating the current treatment landscape for achieving hepatitis C virus elimination among persons who inject drugs
Mark S Sulkowski, Anthony Martinez, Gia L Tyson, et al.
Journal of Viral Hepatitis
|
December 24, 2017
Efficacy and safety of 6 or 8 weeks of simeprevir, daclatasvir, sofosbuvir for HCV genotype 1 infection
M S Sulkowski, J J Feld, E Lawitz, et al.
Antiviral Therapy
|
March 8, 2006
A Phase I/II study evaluating escalating doses of recombinant human albumin-interferon-alpha fusion protein in chronic hepatitis C patients who have failed previous interferon-alpha-based therapy
Vijayan Balan, David R Nelson, Mark S Sulkowski, et al.
The Journal of Clinical Investigation
|
February 3, 2025
Transcription of hepatitis B surface antigen shifts from cccDNA to integrated HBV DNA during treatment
Maraake Taddese, Tanner Grudda, Giulia Belluccini, et al.
The Lancet. Infectious Diseases
|
December 10, 2014
Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study
Sunil Suhas Solomon, Shruti H Mehta, Aylur K Srikrishnan, et al.
World Journal of Gastroenterology
|
August 14, 2025
Poor sleep and hepatic steatosis contribute to poorer quality of life in people with human immunodeficiency virus
Ana N Hyatt, Sai K Kuchana, Eduardo Vilar-Gomez, et al.
Alimentary Pharmacology & Therapeutics
|
December 29, 2023
Prevalence of steatotic liver disease, MASLD, MetALD and significant fibrosis in people with HIV in the United States
Samer Gawrieh, Eduardo Vilar-Gomez, Tinsay A Woreta, et al.
The New England Journal of Medicine
|
April 1, 2011
Boceprevir for untreated chronic HCV genotype 1 infection
Fred Poordad, Jonathan McCone, Bruce R Bacon, et al.
Page
of 41
Search research articles
Search
Showing results (341-350 of 408) with videos related to
Sort By:
Page
of 41
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 9, 2008
Safety and antiviral activity of albinterferon alfa-2b in prior interferon nonresponders with chronic hepatitis C
David R Nelson, Vinod Rustgi, Vijayan Balan, et al.
Open Forum Infectious Diseases
|
May 8, 2026
Non-Hispanic Black Persons With HIV Have a Lower Risk of Metabolic Dysfunction-Associated Steatotic Liver Disease and Clinically Significant Fibrosis Compared to Non-Hispanic White and Hispanic Individuals
Tinsay A Woreta, Samer Gawrieh, Laura A Wilson, et al.
Journal of Viral Hepatitis
|
March 4, 2024
Leveraging opportunities for treatment/user simplicity (LOTUS): Navigating the current treatment landscape for achieving hepatitis C virus elimination among persons who inject drugs
Mark S Sulkowski, Anthony Martinez, Gia L Tyson, et al.
Journal of Viral Hepatitis
|
December 24, 2017
Efficacy and safety of 6 or 8 weeks of simeprevir, daclatasvir, sofosbuvir for HCV genotype 1 infection
M S Sulkowski, J J Feld, E Lawitz, et al.
Antiviral Therapy
|
March 8, 2006
A Phase I/II study evaluating escalating doses of recombinant human albumin-interferon-alpha fusion protein in chronic hepatitis C patients who have failed previous interferon-alpha-based therapy
Vijayan Balan, David R Nelson, Mark S Sulkowski, et al.
The Journal of Clinical Investigation
|
February 3, 2025
Transcription of hepatitis B surface antigen shifts from cccDNA to integrated HBV DNA during treatment
Maraake Taddese, Tanner Grudda, Giulia Belluccini, et al.
The Lancet. Infectious Diseases
|
December 10, 2014
Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study
Sunil Suhas Solomon, Shruti H Mehta, Aylur K Srikrishnan, et al.
World Journal of Gastroenterology
|
August 14, 2025
Poor sleep and hepatic steatosis contribute to poorer quality of life in people with human immunodeficiency virus
Ana N Hyatt, Sai K Kuchana, Eduardo Vilar-Gomez, et al.
Alimentary Pharmacology & Therapeutics
|
December 29, 2023
Prevalence of steatotic liver disease, MASLD, MetALD and significant fibrosis in people with HIV in the United States
Samer Gawrieh, Eduardo Vilar-Gomez, Tinsay A Woreta, et al.
The New England Journal of Medicine
|
April 1, 2011
Boceprevir for untreated chronic HCV genotype 1 infection
Fred Poordad, Jonathan McCone, Bruce R Bacon, et al.
Page
of 41